Search Result for:
New Online Offerings
Browse:
Education by Topic
New Online Offerings
Certificate Programs
Translated Offerings
Annual Global Meeting
Sort By
This interactive 90-minute symposium will explore the evolving treatment landscape in endometrial cancer, focusing on the distinctions between dMMR and pMMR disease.
On-Demand
Kathleen Moore details outcome measures from three major phase III trials—KEYNOTE-B96, ROSELLA, and MIRASOL—highlighting objective response rates, progression-free and overall survival, and key safety signals.
On-Demand
Curated film collection reviewed by global surgical experts showcasing gynecologic oncology surgery procedures and techniques. Films provide practical learning through surgical demonstrations. 
Library
Hear from gynecologic oncology nursing and allied health professionals from around the world for an engaging, solutions-focused program that empowers the vital role of nursing in gynecologic cancer care. 
On-Demand
Dr. Robert Coleman with moderation by Dr. Floor Backes and Dr. Wendel Naumman. Dr. Coleman explores the evolving treatment strategies for recurrent platinum-sensitive ovarian cancer, drawing on the latest clinical trial data and real-world outcomes.
On-Demand
In this special IGCS podcast episode, we spotlight the United Kingdom’s groundbreaking National Lynch Syndrome Project and its free, globally accessible e-learning modules that equip healthcare professionals with the knowledge and skills to implement genetic testing for Lynch syndrome in gynecologic oncology.
On-Demand
This 2-hour webinar will bring together international experts to explore evolving molecular insights, treatment trends, and clinical challenges in uterine cancer through lectures and a tumor board discussion.
On-Demand
Journal Club moderated by IGCS Palliative Care co-chairs Dr. Peter Grant (Australia) and Dr. Anisa Mburu (Kenya) featuring the article
What happens after menopause? (WHAM): A prospective controlled study of vasomotor symptoms and menopause-related quality of life 24 months after premenopausal risk-reducing salpingo-oophorectomy (RRSO). 
On-Demand
Discssion on article Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB–IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study.
On-Demand
 This course offers an in-depth exploration of personalized treatment approaches for endometrial cancers, focusing on proficient mismatch repair (pMMR), deficient mismatch repair (dMMR) diseases and molecular classification in the recurrent setting.
On-Demand
Listen to a new Journal Club with PI Dr. Brian Slomovitz and moderator Dr. Leslie Randall as they discuss details on the New England Journal of Medicine published article Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer.
On-Demand
Listen to a new Journal Club with lead author Dr. Angeles Alvarez Secord and moderator Dr. Robert Coleman as they discuss details on the recently published article The Efficacy and Safety of Mirvetuximab Soravtansine in FRα-Positive, Third-Line and Later, Recurrent Platinum-Sensitive Ovarian Cancer: The Single-Arm Phase 2 PICCOLO Trial.
On-Demand
Interview with IGCS radiation oncologist board member Dr. David Gaffney and with Professor Carien Creutzberg, recipient of the IGCS 2024 Lifetime Achievement Award.
On-Demand
The inaugural IGCS Nursing Symposium offered nurses and healthcare providers an opportunity for networking and education focused on the care of women with gynecologic cancers.
On-Demand
Results of Phase II PICCOLO Trial are available. Dr. Angeles Alvarez Secord, PI of PICCOLO Trial, and Dr. Wendel Naumann discuss results of MIRV in Recurrent Platinum-Sensitive Ovarian Cancer with High Folate Receptor-Alpha Expression.  
On-Demand
This 90 minute webinar is given from the perspective of a physician and a nurse that specialize in brachytherapy, with an in-depth focus on nursing care for patients receiving gynecologic brachytherapy.
On-Demand
Treatment options for patients with advanced or recurrent endometrial cancers are rapidly evolving. Dr. Vicky Makker shares recent report from ASCO 2024 on Selinexor, a novel oral maintenance therapy for patients with TP53 wild type advanced or recurrent endometrial cancer. 
On-Demand
In this session, we will review new and evolving uterine mesenchymal entities as well as biomarker and molecular assays to aid in these diagnoses.
On-Demand
Course 1 to 20 of 56